These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1222683)

  • 21. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 3rd communication: placental transfer and excretion into milk in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Feb; 47(2):201-8. PubMed ID: 9079241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic studies of cyclocytidine and arabinosylcytosine in dogs.
    Ho DH; Carter CJ; Loo TL; Abbott RL; McBride CM
    Drug Metab Dispos; 1975; 3(4):309-13. PubMed ID: 240662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism and disposition of a thiazolobenzimidazole active against human immunodeficiency virus-1.
    el Dareer SM; Tillery KF; Rose LM; Posey CF; Struck RF; Stiller SW; Hill DL
    Drug Metab Dispos; 1993; 21(2):231-5. PubMed ID: 8097690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration.
    Tegeder I; Muth-Selbach U; Lötsch J; Rüsing G; Oelkers R; Brune K; Meller S; Kelm GR; Sörgel F; Geisslinger G
    Clin Pharmacol Ther; 1999 Apr; 65(4):357-68. PubMed ID: 10223771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of diethylpropion and d-amphetamine after subcutaneous and oral administration.
    Jasinski DR; Nutt JG; Griffith JD
    Clin Pharmacol Ther; 1974 Oct; 16(4):645-52. PubMed ID: 4607788
    [No Abstract]   [Full Text] [Related]  

  • 27. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ethylene glycol. II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
    Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B
    Xenobiotica; 1996 Nov; 26(11):1195-220. PubMed ID: 8948094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin.
    Bénès L; Claustrat B; Horrière F; Geoffriau M; Konsil J; Parrott KA; DeGrande G; McQuinn RL; Ayres JW
    J Pharm Sci; 1997 Oct; 86(10):1115-9. PubMed ID: 9344167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-evaluation of the metabolism and excretion of diethylpropion in non-sustained and sustained release formulations.
    Beckett AH; Stanojcić M
    J Pharm Pharmacol; 1987 Jun; 39(6):409-15. PubMed ID: 2886596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies in the psychological effects of a new drug (diethylpropion). Time curves for five subjective variables.
    Jonsson CO; Sjöberg L
    Scand J Psychol; 1967; 8(1):39-46. PubMed ID: 5341243
    [No Abstract]   [Full Text] [Related]  

  • 32. STUDIES IN THE PSYCHOLOGICAL EFFECTS OF A NEW DRUG (DIETHYLPROPION). SUBJECTIVE EFFECTS IN THE NATURAL ENVIRONMENT.
    JONSSON CO; SJOEBERG L; VALLBO S
    Scand J Psychol; 1965; 20():52-8. PubMed ID: 14315413
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of Tenuate (an anorexiant) on migraine.
    Mousa GY
    Am J Optom Physiol Opt; 1983 Jun; 60(6):538-9. PubMed ID: 6881285
    [No Abstract]   [Full Text] [Related]  

  • 34. Diethylpropion in the clinical management of obese patients.
    PERLSTEIN IB
    Appl Ther; 1962 Dec; 4():1110-25 passim. PubMed ID: 13942490
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of poisoning by diethylpropion (Danylen)].
    SJOGREN I; WRANNE L
    Sven Lakartidn; 1961 Nov; 58():3184-6. PubMed ID: 13913549
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacological study of 2-diethylaminopropiophenone. I. Toxicity].
    CAHEN R; MONTAGNE J; PESSONNIER J; PESSONNIER A
    Therapie; 1962; 17():373-83. PubMed ID: 13875544
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of drugs in the treatment of obesity.
    Douglas JG; Munro JF
    Drugs; 1981 May; 21(5):362-73. PubMed ID: 7014176
    [No Abstract]   [Full Text] [Related]  

  • 38. The objective and timing of drug disposition studies, appendix III. Diethylpropion and its metabolites in the blood plasma of the human after subcutaneous and oral administration.
    Wright GJ; Lang JF; Lemieux RE; Goodfriend MJ
    Drug Metab Rev; 1975; 4(2):267-76. PubMed ID: 1222683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of the oral, intravenous, and subcutaneous administration of 3H-naltrexone to normal male volunteers.
    Perez-Reyes M; Wall ME
    NIDA Res Monogr; 1981; 28():93-101. PubMed ID: 6791016
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.